The analysis of GC-MS data shows that the abundance of 13 VOCs changes between different breast cancer cell lines and is sensitive to the cell doubling time (CDT) and to the expression of specific prognostic factors such as Estrogen Receptor (ER), Progesterone Receptor (PgR) and HER2. The gene discussed is ERBB2; the disease is breast carcinoma.